| Steven H Mitchell, MD | |
|
325 9th Ave, Seattle, WA 98104-2420 | |
| (206) 731-3074 | |
| Not Available |
| Full Name | Steven H Mitchell |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 325 9th Ave, Seattle, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760422604 | NPI | - | NPPES |
| 8426058 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD00044990 (Washington) | Primary |
| Entity Name | The Association Of University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244 |
News Archive
Ohr Pharmaceutical Inc. is developing OHR/AVR118 for treatment of cachexia based on technology acquired earlier this year from Advanced Viral Research Corp. OHR/AVR118 has shown excellent therapeutic efficacy and safety in human clinical trials in over 100 patients with applications for cachexia in Cancer and AIDS patients, as well as Rheumatoid Arthritis.
Individuals who have higher levels of education and who are more impaired by Parkinson's disease appear to require treatment for their symptoms earlier than do other patients, according to a report posted online today that will appear in the September print issue of Archives of Neurology, one of the JAMA/Archives journals.
Today the federal government released the most comprehensive data yet about who signed up for Obamacare through Dec. 28. There's reason to cheer for both the law's supporters and its detractors. ... Today's numbers don't settle the question of whether the administration will hit its goals for enrollment in the exchanges, measured either in raw numbers or demographic breakdown. But they show that those goals are within reach (Christopher Flavelle, 1/13).
Inside U.S. Trade features an interview with HHS Assistant Secretary forAffairs Nils Daulaire, who discusses how "the department is playing a larger role than ever before in the development of U.S. trade policy, including on sensitive issues in the Trans-Pacific Partnership (TPP) negotiations like a draft proposal for a tobacco-specific 'safe harbor' and the U.S. stance on issues related to intellectual property protections for pharmaceuticals," according to the publication.
› Verified 6 days ago
| Entity Name | University Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326002049 PECOS PAC ID: 3274445150 Enrollment ID: O20040105000544 |
News Archive
Ohr Pharmaceutical Inc. is developing OHR/AVR118 for treatment of cachexia based on technology acquired earlier this year from Advanced Viral Research Corp. OHR/AVR118 has shown excellent therapeutic efficacy and safety in human clinical trials in over 100 patients with applications for cachexia in Cancer and AIDS patients, as well as Rheumatoid Arthritis.
Individuals who have higher levels of education and who are more impaired by Parkinson's disease appear to require treatment for their symptoms earlier than do other patients, according to a report posted online today that will appear in the September print issue of Archives of Neurology, one of the JAMA/Archives journals.
Today the federal government released the most comprehensive data yet about who signed up for Obamacare through Dec. 28. There's reason to cheer for both the law's supporters and its detractors. ... Today's numbers don't settle the question of whether the administration will hit its goals for enrollment in the exchanges, measured either in raw numbers or demographic breakdown. But they show that those goals are within reach (Christopher Flavelle, 1/13).
Inside U.S. Trade features an interview with HHS Assistant Secretary forAffairs Nils Daulaire, who discusses how "the department is playing a larger role than ever before in the development of U.S. trade policy, including on sensitive issues in the Trans-Pacific Partnership (TPP) negotiations like a draft proposal for a tobacco-specific 'safe harbor' and the U.S. stance on issues related to intellectual property protections for pharmaceuticals," according to the publication.
› Verified 6 days ago
| Entity Name | Harborview Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568557312 PECOS PAC ID: 3971404716 Enrollment ID: O20040115000760 |
News Archive
Ohr Pharmaceutical Inc. is developing OHR/AVR118 for treatment of cachexia based on technology acquired earlier this year from Advanced Viral Research Corp. OHR/AVR118 has shown excellent therapeutic efficacy and safety in human clinical trials in over 100 patients with applications for cachexia in Cancer and AIDS patients, as well as Rheumatoid Arthritis.
Individuals who have higher levels of education and who are more impaired by Parkinson's disease appear to require treatment for their symptoms earlier than do other patients, according to a report posted online today that will appear in the September print issue of Archives of Neurology, one of the JAMA/Archives journals.
Today the federal government released the most comprehensive data yet about who signed up for Obamacare through Dec. 28. There's reason to cheer for both the law's supporters and its detractors. ... Today's numbers don't settle the question of whether the administration will hit its goals for enrollment in the exchanges, measured either in raw numbers or demographic breakdown. But they show that those goals are within reach (Christopher Flavelle, 1/13).
Inside U.S. Trade features an interview with HHS Assistant Secretary forAffairs Nils Daulaire, who discusses how "the department is playing a larger role than ever before in the development of U.S. trade policy, including on sensitive issues in the Trans-Pacific Partnership (TPP) negotiations like a draft proposal for a tobacco-specific 'safe harbor' and the U.S. stance on issues related to intellectual property protections for pharmaceuticals," according to the publication.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven H Mitchell, MD Po Box 50095, Seattle, WA 98145-5095 Ph: (206) 543-6420 | Steven H Mitchell, MD 325 9th Ave, Seattle, WA 98104-2420 Ph: (206) 731-3074 |
News Archive
Ohr Pharmaceutical Inc. is developing OHR/AVR118 for treatment of cachexia based on technology acquired earlier this year from Advanced Viral Research Corp. OHR/AVR118 has shown excellent therapeutic efficacy and safety in human clinical trials in over 100 patients with applications for cachexia in Cancer and AIDS patients, as well as Rheumatoid Arthritis.
Individuals who have higher levels of education and who are more impaired by Parkinson's disease appear to require treatment for their symptoms earlier than do other patients, according to a report posted online today that will appear in the September print issue of Archives of Neurology, one of the JAMA/Archives journals.
Today the federal government released the most comprehensive data yet about who signed up for Obamacare through Dec. 28. There's reason to cheer for both the law's supporters and its detractors. ... Today's numbers don't settle the question of whether the administration will hit its goals for enrollment in the exchanges, measured either in raw numbers or demographic breakdown. But they show that those goals are within reach (Christopher Flavelle, 1/13).
Inside U.S. Trade features an interview with HHS Assistant Secretary forAffairs Nils Daulaire, who discusses how "the department is playing a larger role than ever before in the development of U.S. trade policy, including on sensitive issues in the Trans-Pacific Partnership (TPP) negotiations like a draft proposal for a tobacco-specific 'safe harbor' and the U.S. stance on issues related to intellectual property protections for pharmaceuticals," according to the publication.
› Verified 6 days ago
Sasha Kaiser, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
Kristopher Allen Hendershot, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
Dr. Lauren Kristen Whiteside, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-744-8464 | |
Brenda Park, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-368-5762 Fax: 814-537-5677 | |
Rhadika Mccormick Souza, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 925 Seneca St, Seattle, WA 98101 Phone: 206-583-6433 Fax: 206-583-6583 | |
Eleanor Ganz, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-598-4955 | |
Dr. Gary H. Somers, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-368-1765 |